GlassScriptPhysician profile
Zachary Mcdowell
NPI 1447637400
$6,397.51
in general payments reported to CMS, 2019-2025
46 companies · $570 in 2025
The $570 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.92 · 2022: $2,168 · 2023: $2,409 · 2024: $1,191 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,445 · Travel and Lodging: $612 · Education: $90.00 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,444.52 |
| Travel and Lodging | $612.10 |
| Education | $90.00 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,412.66 | 2023-2024 | Da Vinci Surgical System |
| Teleflex LLC | $615.96 | 2022-2024 | Urolift |
| Dendreon Pharmaceuticals LLC | $415.51 | 2022-2024 | Provenge |
| Procept Biorobotics Corporation | $314.38 | 2022-2024 | Aquabeam System |
| Sumitomo Pharma America, INC. | $246.37 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $244.65 | 2023 | Prolaris, Precisetumor |
| Progenics Pharmaceuticals, INC. | $229.08 | 2022-2025 | Pylarify |
| Janssen Biotech, INC. | $228.52 | 2022-2025 | Erleada |
| Conmed Corporation | $198.40 | 2022-2023 | Airseal |
| Urogen Pharma, INC. | $187.28 | 2022-2025 | Jelmyto |
| Astellas Pharma US INC | $185.76 | 2022-2025 | Myrbetriq, Xtandi |
| Abbvie INC. | $170.34 | 2022-2025 | |
| Storz Medical America, INC. | $143.45 | 2023 | |
| Merck Sharp & Dohme LLC | $137.90 | 2022-2024 | Keytruda |
| Coloplast Corp | $136.17 | 2021-2024 | Titan, Speedicath |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Mcdowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.